Table 1.
Demographic character | Data |
---|---|
Age (years): | Mean: 57.2, Range: 42 to 72 |
Menopause: | 25 postmenopausal (69.4%) |
Pathology: | 9 postmenopausal vaginal bleeding or irregular vaginal bleeding (25.0%) |
12 vaginal discharge (33.3%) | |
9 abdominal distension or abdominal pain (25.0%) | |
1 back pain | |
4 asymptomatic yet with pelvic mass (11.1%) | |
1 poorly differentiated carcinoma | |
Preoperative screening: | 28 preoperative cervical TCT 6 curettage |
Surgical method: | 1 left oophorectomy and partial omentum resection |
35 uterine double oophorectomy | |
31 pelvic an/or aortic lymph node dissection | |
35 full or partial omental resection | |
20 cytoreductive surgery | |
Adjuvant therapies: | |
Chemotherapy: | 1 one-course preoperative neoadjuvant chemotherapy |
35 four- to eight-course postoperative chemotherapy | |
31 TP | |
4 cisplatin and PC, or cisplatin, PC and PAC | |
Radiotherapy: | 1 radiotherapy after six-course chemotherapy |
Abbreviation: TCT thinpprep cytology test, TP taxol and cisplatin, PC cisplatin and cyclophosphamide, PAC cisplatin, adriamycin and cyclophosphamide.